Narcolepsy is often a paediatric disorder with symptoms that can commence in early childhood, and new diagnoses that peak at 15 years of age (Postiglione et al., 2018). For this reason we need controlled safe and effective pharmacological treatments to manage narcolepsy symptoms in young people.
This has been a continued struggle for paediatric patients with narcolepsy, who have been at risk of becoming therapeutic orphans, without considerable advocacy (Lecendreux et al., 2012).